Breaking News Instant updates and real-time market news.

2021-04-06 14:08:16 AZN AstraZeneca $49.51 / -0.03 (-0.06%) 14:08 04/06/21 04/06 14:08 04/06/21 14:08	Oxford halts dosing in AstraZeneca vaccine trial in children, teens, WSJ says The University of Oxford said it has halted administration of doses of the COVID-19 vaccine it co-developed with AstraZeneca in a small U.K. study to test the vaccine in children and teens, pending further information about rate blood-clotting issues in some individuals who have received the shot, the Wall Street Journal's Jenny Strasburg and Eric Sylvers report. An Oxford spokesman told the Journal that no safety issues have come about in the trial itself, though broader worries about rare clotting issues in adults have triggered additional regulatory examination in the U.K. and Europe to investigate any potential connection to the vaccine. Reference Link	06 May
AZN AstraZeneca $49.51 / -0.03 (-0.06%) 03/26/21 Piper Sandler AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler 03/23/21 Societe Generale AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale 03/18/21 Deutsche Bank AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank 03/16/21 Fly Intel: Top five analyst upgrades

2021-04-06 14:08:16

AZN

AstraZeneca

$49.51 / -0.03 (-0.06%)

14:08

04/06/21

04/06

14:08

04/06/21

14:08

Oxford halts dosing in AstraZeneca vaccine trial in children, teens, WSJ says

The University of Oxford said it has halted administration of doses of the COVID-19 vaccine it co-developed with AstraZeneca in a small U.K. study to test the vaccine in children and teens, pending further information about rate blood-clotting issues in some individuals who have received the shot, the Wall Street Journal's Jenny Strasburg and Eric Sylvers report. An Oxford spokesman told the Journal that no safety issues have come about in the trial itself, though broader worries about rare clotting issues in adults have triggered additional regulatory examination in the U.K. and Europe to investigate any potential connection to the vaccine. Reference Link

06
May

AZN AstraZeneca

$49.51 / -0.03 (-0.06%)

03/26/21 Piper Sandler: AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler

03/23/21 Societe Generale: AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale

03/18/21 Deutsche Bank: AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank

03/16/21: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks	Splunk CEO sells 15.5K shares of common stock » 20:28 04/13/21 04/13 20:28 04/13/21 20:28 SPLK Splunk $147.69 / +3.07 (+2.12%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPLK Splunk $147.69 / +3.07 (+2.12%) 04/05/21 Splunk appoints Teresa Carlson as Chief Growth Officer 03/21/21 Fly Intel: Top five weekend stock stories 03/16/21 Okta appoints Steve Rowland as CRO 03/04/21 Splunk CEO: We're growing our cloud business like no tomorrow SPLK Splunk $147.69 / +3.07 (+2.12%) 04/08/21 BofA Splunk reinstated with a Buy at BofA 04/08/21 BofA Splunk reinstated with a Buy at BofA 04/05/21 Goldman Sachs Splunk chief growth officer hire a 'significant positive,' says Goldman Sachs 03/15/21 Credit Suisse Splunk assumed with an Outperform at Credit Suisse SPLK Splunk $147.69 / +3.07 (+2.12%) 03/03/21 Splunk sees Q1 revenue $480M-$500M, consensus $507.29M 03/03/21 Splunk reports Q4 EPS (86c) vs (15c) last year 03/03/21 Notable companies reporting after market close 12/02/20 Splunk withdrawing FY23 ARR and operating cash flow targets SPLK Splunk $147.69 / +3.07 (+2.12%) 03/20/21 Splunk stock could soar, Barron's says 11/03/20 UK government in talks with Palantir about 'test-and-trace' program, FT says SPLK Splunk $147.69 / +3.07 (+2.12%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 03/04/21 Fly Intel: Pre-market Movers 03/03/21 Fly Intel: After-Hours Movers 04/15/21 Cybersecurity SPLK Splunk $147.69 / +3.07 (+2.12%) 03/03/21 Splunk options imply 14.5% move in share price post-earnings 12/23/20 Splunk call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/21/20 Splunk call volume above normal and directionally bullish
Periodicals	KKR, Brookfield Asset Management mulling bid for Toshiba, Bloomberg reports 20:22 04/13/21 04/13 20:22 04/13/21 20:22 TOSBF Toshiba, also use TOSYY $44.83 / +4.41 (+10.91%) , TOSYY Toshiba $23.28 / +2.43 (+11.65%) , KKR KKR $52.04 / +0.025 (+0.05%) , BAM Brookfield $45.52 / -0.44 (-0.96%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events TOSYY KKR BAM TOSYY Toshiba $23.28 / +2.43 (+11.65%) 04/09/21 Toshiba chairperson Osamu Nagayama comments on CVC Capital acquisition proposal 04/06/21 Toshiba confirms acquisition proposal from CVC Capital 03/02/21 Farallon Capital urges Toshiba shareholders to support Farallon EGM proposal KKR KKR $52.04 / +0.025 (+0.05%) 12:42 Today Epic Games completes $1B round of funding, including $200M investment from Sony 04/08/21 KKR to lead purchase of $500M of convertible preferred stock in Box 04/08/21 Box reaffirms vision to deliver Content Cloud, drive profitable growth 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment BAM Brookfield $45.52 / -0.44 (-0.96%) 04/01/21 Brookfield to acquire all of Brookfield Property units for $6.5B 03/22/21 Brookfield appoints Calin Rovinescu as senior advisor 02/11/21 Brookfield announces pricing of secondary public offering 01/04/21 Brookfield Property establishes committee to review Brookfield proposal TOSBF TOSYY KKR BAM TOSBF Toshiba, also use TOSYY $44.83 / +4.41 (+10.91%) 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS TOSYY Toshiba $23.28 / +2.43 (+11.65%) 03/19/21 SMBC Nikko Toshiba upgraded to Outperform from Neutral at SMBC Nikko 02/19/21 Citi Toshiba resumed with a Neutral at Citi 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS KKR KKR $52.04 / +0.025 (+0.05%) 04/09/21 DA Davidson Box price target lowered to $22 from $25 at DA Davidson 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/07/21 Seaport Global Seaport downgrades Sempra Energy to Neutral after 'good, not great' SIP deal BAM Brookfield $45.52 / -0.44 (-0.96%) 04/09/21 Deutsche Bank Brookfield price target raised to $45 from $43 at Deutsche Bank 04/01/21 Evercore ISI Brookfield Property downgraded to In Line from Outperform at Evercore ISI 03/31/21 Fly Intel: Top five analyst downgrades 03/31/21 Credit Suisse Brookfield downgraded to Neutral from Outperform at Credit Suisse KKR BAM KKR KKR $52.04 / +0.025 (+0.05%) 02/08/21 KKR reports Q4 EPS 49c, consensus 40c 02/08/21 Notable companies reporting after market close 10/30/20 KKR reports Q3 EPS 48c, consensus 40c BAM Brookfield $45.52 / -0.44 (-0.96%) 11/12/20 Brookfield reports Q3 EPS 10c, consensus 47c 11 Nov TOSBF TOSYY KKR BAM TOSBF Toshiba, also use TOSYY $44.83 / +4.41 (+10.91%) 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports TOSYY Toshiba $23.28 / +2.43 (+11.65%) 11:23 Today KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports 04/06/21 CVC to propose taking Toshiba private at 30% premium, Nikkei says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/18/20 Toshiba shareholder escalates dispute with management, FT reports KKR KKR $52.04 / +0.025 (+0.05%) 15:33 Today KKR near deal to buy IT services provider Ensono, Reuters says 11:23 Today KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports 03/23/21 Thoma Bravo to acquire Calabrio from KKR, no terms, Reuters reports 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports BAM Brookfield $45.52 / -0.44 (-0.96%) 02/10/21 Brookfield weighing IPO for battery maker Clarios this year, Bloomberg says 02/10/21 Brookfield weighing IPO for battery maker Clarios this year, Bloomberg says 01/20/21 Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says 11/10/20 Brookfield seeks to enter secondary market for private assets, Bloomberg says TOSYY KKR BAM TOSYY Toshiba $23.28 / +2.43 (+11.65%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday KKR KKR $52.04 / +0.025 (+0.05%) 12:34 Today Game On: GameStop may be looking for new CEO 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Game On: Microsoft completes Bethesda deal, promises exclusive games BAM Brookfield $45.52 / -0.44 (-0.96%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 05/13/21 Brookfield - BAM 08:30 Today KKR & Co. Inc. 06/11/21 Brookfield Asset Management Inc.
Earnings	Steel Partners reports Q4 adjusted EBITDA $67.1M vs. $46.6M last year » 20:12 04/13/21 04/13 20:12 04/13/21 20:12 SPLP Steel Partners $14.35 / + (+0.00%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly SPLP Steel Partners $14.35 / + (+0.00%) 01/15/21 Steel Partners rises 16.2% 01/15/21 Steel Partners rises 15.7% 01/14/21 Steel Partners director buys 77.3K shares of common stock 12/30/20 Steel Partners rises 21.3% SPLP Steel Partners $14.35 / + (+0.00%) 11/03/20 Steel Partners reports Q3 adj. EBITDA $73.3M vs. $59.2M last year SPLP Steel Partners $14.35 / + (+0.00%) 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades
Initiation	Retail Opportunity reinstated with an Outperform at Baird » 20:06 04/13/21 04/13 20:06 04/13/21 20:06 ROIC Retail Opportunity $16.49 / +0.085 (+0.52%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ROIC Retail Opportunity $16.49 / +0.085 (+0.52%) 03/02/21 Retail Opportunity appoints Angela Ho to board of directors ROIC Retail Opportunity $16.49 / +0.085 (+0.52%) 02/24/21 DA Davidson Retail Opportunity price target raised to $18 from $12 at DA Davidson 01/19/21 BofA Retail Opportunity double-upgraded to Buy from Underperform at BofA 01/19/21 BofA Retail Opportunity upgraded to Buy from Underperform at BofA 12/14/20 KeyBanc Retail Opportunity downgraded to Sector Weight from Overweight at KeyBanc ROIC Retail Opportunity $16.49 / +0.085 (+0.52%) 02/23/21 Retail Opportunity sees FY21 FFO 95c-$1.02, consensus $1.02 02/23/21 Retail Opportunity reports Q4 FFO 27c, consensus 26c 10/26/20 Retail Opportunity reports Q3 FFO 25c, consensus 23c 04/28/21 Retail Opportunity - ROIC 04/26/21 Retail Opportunity Investments Corp
Initiation	RPT Realty reinstated with a Neutral at Baird » 20:06 04/13/21 04/13 20:06 04/13/21 20:06 RPT RPT Realty $11.83 / +0.025 (+0.21%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RPT RPT Realty $11.83 / +0.025 (+0.21%) 03/08/21 RPT Realty names Tyler Sorenson as MD for net lease retail real estate platform 03/04/21 RPT Realty announces formation of net lease retail real estate platform RPT RPT Realty $11.83 / +0.025 (+0.21%) 01/13/21 Jefferies Jefferies upgrades 'overlooked' RPT Realty to Buy 01/13/21 Jefferies RPT Realty upgraded to Buy from Hold at Jefferies 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 12/21/20 JPMorgan RPT Realty upgraded to Neutral from Underweight at JPMorgan RPT RPT Realty $11.83 / +0.025 (+0.21%) 02/17/21 RPT Realty reports Q4 EPS (9c), consensus (5c) 02/17/21 RPT Realty reports Q4 EPS (9c), consensus (5c) 05/06/21 RPT Realty - RPT 04/28/21 RPT Reality

Initiation	Retail Properties of America reinstated with a Neutral at Baird » 20:04 04/13/21 04/13 20:04 04/13/21 20:04 RPAI Retail Properties of America $10.90 / -0.005 (-0.05%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RPAI Retail Properties of America $10.90 / -0.005 (-0.05%) 12/08/20 Retail Properties of America raises quarterly dividend to 6c from 5c per share RPAI Retail Properties of America $10.90 / -0.005 (-0.05%) 03/04/21 Fly Intel: Top five analyst downgrades 03/04/21 KeyBanc Retail Properties of America downgraded to Sector Weight at KeyBanc 03/04/21 KeyBanc Retail Properties downgraded to Sector Weight from Overweight at KeyBanc 12/15/20 Citi Retail Properties of America price target raised to $9.50 from $7 at Citi RPAI Retail Properties of America $10.90 / -0.005 (-0.05%) 02/16/21 Retail Properties of America sees FY21 operating FFO 76c-84c 02/16/21 Retail Properties of America reports Q4 operating FFO 20c, consensus 21c 11/02/20 Retail Properties of America reports Q3 operating FFO 21, consensus 20c 05/05/21 Retail Properties of America - RPAI 05/27/21 Retail Properties of America Inc
Initiation	Regency Centers reinstated with a Neutral at Baird » 20:04 04/13/21 04/13 20:04 04/13/21 20:04 REG Regency Centers $59.24 / +0.84 (+1.44%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options REG Regency Centers $59.24 / +0.84 (+1.44%) 03/02/21 PS Business Parks appoints Dan Chandler as CEO 03/02/21 Regency Centers chief investment officer Mac Chandler to resign 01/27/21 Regency Centers issues TCFD Climate Change Risk Report 01/19/21 Regency Centers sold five shopping centers in Q4 for $77.8M REG Regency Centers $59.24 / +0.84 (+1.44%) 03/31/21 Truist Regency Centers price target raised to $57 from $50 at Truist 03/16/21 Wells Fargo Regency Centers price target raised to $63 from $52 at Wells Fargo 03/04/21 Argus Regency Centers downgraded to Hold from Buy at Argus 03/04/21 Argus Regency Centers downgraded to Hold from Buy at Argus REG Regency Centers $59.24 / +0.84 (+1.44%) 02/11/21 Regency Centers sees FY21 FFO $2.96-$3.14, consensus $3.31 02/11/21 Regency Centers reports Q4 FFO 76c, consensus 72c 11/05/20 Regency Centers reports Q3 EPS 7c, consensus 21c 05/07/21 Regency Centers - REG 05/05/21 Regency Centers Corporation 05/25/21 Regency Centers REG Regency Centers $59.24 / +0.84 (+1.44%) 12/29/20 Early notable gainers among liquid option names on December 29th
Initiation	Kimco Realty reinstated with an Outperform at Baird » 20:02 04/13/21 04/13 20:02 04/13/21 20:02 KIM Kimco Realty $19.68 / +0.22 (+1.13%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options KIM Kimco Realty $19.68 / +0.22 (+1.13%) 01/27/21 Kimco Realty doubles solar installations as part of expanding ESG commitment KIM Kimco Realty $19.68 / +0.22 (+1.13%) 20:00 Today Baird Kimco Realty reinstated with an Outperform at Baird 03/05/21 Truist Kimco Realty price target raised to $20 from $18 at Truist 02/12/21 Mizuho Kimco Realty price target raised to $20 from $17 at Mizuho 01/11/21 Mizuho Kimco Realty upgraded to Buy from Neutral at Mizuho KIM Kimco Realty $19.68 / +0.22 (+1.13%) 02/11/21 Kimco Realty sees FY21 FFO $1.18-$1.24 02/11/21 Kimco Realty reports Q4 FFO 31c, consensus 30c 11/05/20 Kimco Realty reports Q3 FFO 25c, consensus 26c 04/29/21 Kimco Realty - KIM 04/27/21 Kimco Realty Corporation KIM Kimco Realty $19.68 / +0.22 (+1.13%) 11/09/20 Early notable gainers among liquid option names on November 9th
Initiation	Weingarten Realty reinstated with an Outperform at Baird » 20:01 04/13/21 04/13 20:01 04/13/21 20:01 WRI Weingarten Realty $27.49 / +0.38 (+1.40%) Baird analyst Wesley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events WRI Weingarten Realty $27.49 / +0.38 (+1.40%) 02/22/21 Weingarten Realty raises quarterly dividend 67% to 30c per share 11/16/20 Weingarten Realty cash collections increase to 91% for Q3, and 90% for October WRI Weingarten Realty $27.49 / +0.38 (+1.40%) 03/09/21 BTIG Weingarten Realty price target raised to $28 from $25 at BTIG 03/05/21 Truist Weingarten Realty price target raised to $28 from $24 at Truist 01/28/21 Scotiabank Weingarten Realty upgraded to Outperform at Scotiabank on 'Sunbelt preference' 01/28/21 Scotiabank Weingarten Realty upgraded to Outperform from Sector Perform at Scotiabank WRI Weingarten Realty $27.49 / +0.38 (+1.40%) 02/22/21 Weingarten Realty sees FY21 core FFO $1.65-$1.75, consensus $1.76 02/22/21 Weingarten Realty sees FY21 core FFO $1.65-$1.75, consensus $1.76 02/22/21 Weingarten Realty reports Q4 core FFO 43c, consensus 42c 04/27/21 Weingarten Realty - WRI 04/26/21 Weingarten Realty Investors
Downgrade	FLSmidth double-downgraded to Sell from Buy at Goldman Sachs » 19:59 04/13/21 04/13 19:59 04/13/21 19:59 FLIDY FLSmidth $3.74 / -0.11 (-2.86%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FLIDY FLSmidth $3.74 / -0.11 (-2.86%) 02/19/21 RBC Capital FLSmidth price target lowered to DKK 255 from DKK 270 at RBC Capital 02/11/21 Morgan Stanley FLSmidth price target lowered to DKK 190 from DKK 200 at Morgan Stanley 12/08/20 Nordea FLSmidth upgraded to Buy from Hold at Nordea 12/07/20 JPMorgan FLSmidth price target raised to DKK 245 from DKK 230 at JPMorgan

Initiation	Epiroc initiated with a Buy at Goldman Sachs » 19:55 04/13/21 04/13 19:55 04/13/21 19:55 EPOKY Epiroc $23.87 / +0.06 (+0.25%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EPOKY Epiroc $23.87 / +0.06 (+0.25%) 12/22/20 Dundee Precious Metals announces sale of MineRP to Epiroc Canada EPOKY Epiroc $23.87 / +0.06 (+0.25%) 15:12 Today UBS Epiroc price target raised to SEK 200 from SEK 159 at UBS 05:18 Today Pareto Epiroc downgraded to Sell from Hold at Pareto 04/12/21 Societe Generale Epiroc downgraded to Hold on valuation at Societe Generale 04/12/21 Societe Generale Epiroc downgraded to Hold from Buy at Societe Generale
Initiation	Metso Outotec reinstated with a Neutral at Goldman Sachs » 19:53 04/13/21 04/13 19:53 04/13/21 19:53 OUKPY Metso Outotec $5.66 / +0.04 (+0.71%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OUKPY Metso Outotec $5.66 / +0.04 (+0.71%) 04/12/21 Societe Generale Metso Outotec price target raised to EUR 11 from EUR 8.40 at Societe Generale 02/19/21 Credit Suisse Metso Outotec price target raised to EUR 10.50 from EUR 9.40 at Credit Suisse 02/17/21 UBS Metso Outotec price target raised to EUR 10.4 from EUR 10 at UBS 02/17/21 Morgan Stanley Metso Outotec price target raised to EUR 9.60 from EUR 9.30 at Morgan Stanley
Upgrade	JFrog upgraded to Hold from Sell at Summit Insights » 19:06 04/13/21 04/13 19:06 04/13/21 19:06 FROG JFrog $51.99 / +0.68 (+1.33%) Summit Insights analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options FROG JFrog $51.99 / +0.68 (+1.33%) 01/26/21 JFrog partners with Docker for cloud-native application development 11/23/20 JFrog falls 2% to $59.99 after announcing early release of IPO lock-up shares 11/23/20 JFrog announces early lock-up release FROG JFrog $51.99 / +0.68 (+1.33%) 01/05/21 Piper Sandler JFrog price target lowered to $65 from $76 at Piper Sandler 11/05/20 Stifel JFrog reported 'strong first print as a public company,' says Stifel 10/26/20 Stifel SAP news impact may be company-specific for software sector, says Stifel 10/12/20 JPMorgan JFrog initiated with an Overweight at JPMorgan FROG JFrog $51.99 / +0.68 (+1.33%) 02/11/21 Notable companies reporting after market close 02/11/21 JFrog sees 2021 revenue $196M-$204M, consensus $195.39M 02/11/21 JFrog sees Q1 EPS 0c-1c, consensus 1c 02/11/21 JFrog reports Q4 EPS 2c, consensus 2c 16 Sep FROG JFrog $51.99 / +0.68 (+1.33%) 12/15/20 JFrog weakness attributed to Hedgeye short call FROG JFrog $51.99 / +0.68 (+1.33%) 11/04/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 05/06/21 JFrog - FROG 05/13/21 JFrog Ltd. FROG JFrog $51.99 / +0.68 (+1.33%) 12/04/20 Largest borrow rate increases among liquid names
Hot Stocks	Galectin says Phase 1 belapectin data published in JITC » 19:03 04/13/21 04/13 19:03 04/13/21 19:03 GALT Galectin Therapeutics $2.17 / -0.105 (-4.62%) Galectin Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings GALT Galectin Therapeutics $2.17 / -0.105 (-4.62%) 04/06/21 Galectin Therapeutics launches NAVIGATEnash.com 03/31/21 Galectin expects cash to fund planned operations through March 31, 2022 03/08/21 Galectin Therapeutics announces publication on belapectin galectin-3 inhibitor 11/09/20 Galectin Therapeutics expects cash to fund operations through at Dec. 31 GALT Galectin Therapeutics $2.17 / -0.105 (-4.62%) 03/31/21 Galectin Therapeutics reports 2020 EPS (41c), one est. (43c) 11/09/20 Galectin Therapeutics reports Q3 EPS (10c), one est. (14c)
Earnings	Washington Federal reports Q2 EPS 56c, consensus 48c » 19:02 04/13/21 04/13 19:02 04/13/21 19:02 WAFD Washington Federal $30.81 / -0.64 (-2.03%) Reports Q2 NII $124.0M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Options WAFD Washington Federal $30.81 / -0.64 (-2.03%) 02/09/21 Washington Federal trading resumes 02/09/21 Washington Federal trading halted, news dissemination 01/26/21 Washington Federal raises quarterly dividend by 4.5% to 23c per share WAFD Washington Federal $30.81 / -0.64 (-2.03%) 01/14/21 Washington Federal reports Q1 EPS 51c, consensus 42c 10/14/20 Washington Federal reports Q4 EPS 45c, consensus 42c WAFD Washington Federal $30.81 / -0.64 (-2.03%) 01/13/21 Washington Federal options imply 10.7% move in share price post-earnings

Hot Stocks	J&J pauses vaccinations in all COVID-19 vaccine clinical trials » 18:54 04/13/21 04/13 18:54 04/13/21 18:54 JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) In an updated statement,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 14:59 Today South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 16:27 Today Fly Intel: Wall Street's top stories for Tuesday 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Hot Stocks	Televisa, Univision agree to combine content, production assets » 18:40 04/13/21 04/13 18:40 04/13/21 18:40 TV Televisa $10.12 / +0.09 (+0.90%) , SFTBY SoftBank $46.60 / +0.155 (+0.33%) Televisa (TV) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events SFTBY SFTBY SoftBank $46.60 / +0.155 (+0.33%) 04/07/21 SoftBank's Vision Fund 2, BlackRock lead $640M funding in Trax 04/05/21 SoftBank to acquire 40% of AutoStore for $2.8B 04/05/21 Invitae announces $1.15B investment supporting ongoing growth initiatives 02/24/21 Berkshire Grey to combine with Revolution Acceleration Acquisition Corp TV SFTBY TV Televisa $10.12 / +0.09 (+0.90%) 03/17/21 BBVA Televisa upgraded to Outperform from Market Perform at BBVA 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight following rally at Morgan Stanley 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight from Overweight at Morgan Stanley 05/12/20 Credit Suisse Televisa upgraded to Outperform from Neutral at Credit Suisse SFTBY SoftBank $46.60 / +0.155 (+0.33%) 03/11/21 Jefferies SoftBank downgraded to Hold from Buy at Jefferies 03/10/21 Morgan Stanley SoftBank resumed with an Equal Weight at Morgan Stanley 11/27/20 Citi SoftBank price target raised to 11,000 yen from 10,200 yen at Citi 09/18/20 Northland Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland TV SFTBY TV Televisa $10.12 / +0.09 (+0.90%) 18:37 Today Televisa to combine content, production assets with Univision, Bloomberg says SFTBY SoftBank $46.60 / +0.155 (+0.33%) 04/08/21 SoftBank invests $500M in Better, brings valuation to about $6B, WSJ says 04/05/21 SoftBank approaches deal to take 40% stake in AutoStore, WSJ reports 03/29/21 Energy Monster ownership dispute ahead of U.S. listing, Reuters reports 03/29/21 CM Life Sciences II nears deal to merge with SomaLogic, WSJ reports SFTBY SFTBY SoftBank $46.60 / +0.155 (+0.33%) 04/04/21 On the Fly: The Week in SPAC News 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO 03/28/21 On the Fly: The Week in SPAC News 03/21/21 On the Fly: The Week in SPAC News 05/12/21 SoftBank - SFTBY
Periodicals	Televisa to combine content, production assets with Univision, Bloomberg says » 18:37 04/13/21 04/13 18:37 04/13/21 18:37 TV Televisa $10.12 / +0.09 (+0.90%) Televisa will receive $3B… Televisa will receive $3B in cash and $1.5B in equity as part of the deal, according to Bloomberg. ShowHide Related Items >><< Street Research TV Televisa $10.12 / +0.09 (+0.90%) 03/17/21 BBVA Televisa upgraded to Outperform from Market Perform at BBVA 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight following rally at Morgan Stanley 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight from Overweight at Morgan Stanley 05/12/20 Credit Suisse Televisa upgraded to Outperform from Neutral at Credit Suisse
Upgrade	Glencore upgraded to Buy from Neutral at Goldman Sachs » 18:35 04/13/21 04/13 18:35 04/13/21 18:35 GLNCY Glencore $7.85 / +0.03 (+0.38%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals GLNCY Glencore $7.85 / +0.03 (+0.38%) 02/11/21 Falco Resources provides update on work program with Glencore 12/18/20 Newmont, Glencore and Yamana Gold announce integration of MARA project 12/10/20 S&P Global WIM used for first LNG futures trade between Glencore, Total 12/04/20 Glencore CEO Ivan Glasenberg to retire, Gary Nagle to succeed GLNCY Glencore $7.85 / +0.03 (+0.38%) 04/12/21 Deutsche Bank Glencore price target raised to 400 GBp from 350 GBp at Deutsche Bank 03/24/21 Morgan Stanley Glencore price target raised to 307 GBp from 274 GBp at Morgan Stanley 03/05/21 JPMorgan Glencore price target raised to 360 GBp from 350 GBp at JPMorgan 03/04/21 UBS Glencore price target raised to 330 GBp from 320 GBp at UBS GLNCY Glencore $7.85 / +0.03 (+0.38%) 03/25/21 Former Glencore trader pleads guilty to manipulating fuel prices, WSJ reports 10/28/20 Biden supports domestic production of EV metals, Reuters reports
Periodicals	Judge says Juul must face new racketeering allegations, Bloomberg says » 18:24 04/13/21 04/13 18:24 04/13/21 18:24 MO Altria Group $51.16 / -0.59 (-1.14%) Juul Labs, which is 35%… Juul Labs, which is 35% owned by Altria, will have to face new racketeering claims accusing the vaping company of deliberately targeting teenagers, as litigation centers on the individual founders and directors of the company, Bloomberg's Joel Rosenblatt reports. A federal judge in San Francisco said that most of the allegations brought by consumers, local governments, and school district against Juul and Altria under the Racketeer Influenced and Corrupt Organizations Act can proceed, the author notes. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MO Altria Group $51.16 / -0.59 (-1.14%) 03/23/21 Altria Group Chairman Thomas Farrell II to retire from board 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 01/10/21 Fly Intel: Top five weekend stock stories 12/10/20 Minnesota AG adds Altria as defendant in Juul marketing lawsuit MO Altria Group $51.16 / -0.59 (-1.14%) 03/26/21 Fly Intel: Top five analyst upgrades 03/26/21 Jefferies Altria Group upgraded to Buy from Hold at Jefferies 03/19/21 Deutsche Bank Altria Group price target raised to $54 from $52 at Deutsche Bank 03/16/21 Fly Intel: Top five analyst downgrades MO Altria Group $51.16 / -0.59 (-1.14%) 02/17/21 Altria Group backs FY21 adjusted EPS view $4.49-$4.62, consensus $4.60 01/28/21 Altria Group sees FY21 adjusted EPS $4.49-$4.62, consensus $4.63 01/28/21 Altria Group reports Q4 adjusted EPS 99c, consensus $1.02 01/27/21 Notable companies reporting before tomorrow's open MO Altria Group $51.16 / -0.59 (-1.14%) 01/09/21 Some century-old stocks still deliver, Barron's says 10/30/20 Altria Group slashes Juul valuation under $5B, WSJ reports 10/29/20 Juul lowers view of valuation to about $10B, WSJ reports 10/23/20 Judge rejects CA claims against Juul in youth vaping cases, Bloomberg says MO Altria Group $51.16 / -0.59 (-1.14%) 03/26/21 Nike, Altria upgrades among today's top calls on Wall Street 03/16/21 Starbucks upgrade, Ulta downgrade among today's top calls on Wall Street 10/30/20 Fly Intel: Pre-market Movers 10/29/20 Fly Intel: Wall Street's top stories for Thursday 04/29/21 Altria Group - MO 05/20/21 Altria Group Inc. MO Altria Group $51.16 / -0.59 (-1.14%) 09:40 Today Unusually active option classes on open April 13th 03/29/21 Unusually active option classes on open March 29th 03/26/21 Altria Group call volume above normal and directionally bullish 03/26/21 Unusually active option classes on open March 26th

Hot Stocks	New Gold reports Q1 gold equivalent production 96,026 ounces » 18:21 04/13/21 04/13 18:21 04/13/21 18:21 NGD New Gold $1.82 / + (+0.00%) Reports Q1 gold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NGD New Gold $1.82 / + (+0.00%) 03/19/21 New Gold announces 14.9% investment in Harte Gold 02/10/21 New Gold provides 2021 operational estimates for Rainy River Mine 02/05/21 New Gold resumes surface operations at New Afton Mine 02/04/21 New Gold provides update on New Afton Mine NGD New Gold $1.82 / + (+0.00%) 02/22/21 Canaccord New Gold price target lowered to C$2.75 from C$3.75 at Canaccord 02/11/21 National Bank New Gold price target lowered to C$4 from C$4.25 at National Bank 02/03/21 CIBC New Gold downgraded to Neutral after mine fatality at CIBC 02/02/21 CIBC New Gold downgraded to Neutral from Outperformer at CIBC NGD New Gold $1.82 / + (+0.00%) 02/18/21 New Gold reports Q4 adjusted EPS 4c, consensus 1c 11/05/20 New Gold reports Q3 adjusted EPS 2c, consensus 1c
On The Fly	Fly Intel: After-Hours Movers » 18:19 04/13/21 04/13 18:19 04/13/21 18:19 SAP SAP $134.51 / +2.08 (+1.57%) , FLXN Flexion $9.37 / +1.05 (+12.62%) , BRKR Bruker $68.97 / +1.43 (+2.12%) , TEAM Atlassian $242.24 / +11.72 (+5.08%) , PKI PerkinElmer $135.39 / +2.695 (+2.03%) , MRNA Moderna $149.63 / +10.34 (+7.42%) , SEAC SeaChange $1.38 / -0.095 (-6.46%) , SFIX Stitch Fix $49.46 / -1.3 (-2.56%) , STSA Satsuma Pharmaceuticals $5.44 / +0.37 (+7.30%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TEAM STSA SFIX SEAC SAP PKI MRNA FLXN BRKR TEAM Atlassian $242.24 / +11.72 (+5.08%) 02/26/21 Atlassian acquires Chartio, terms not disclosed 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 STSA Satsuma Pharmaceuticals $5.44 / +0.37 (+7.30%) 03/01/21 Satsuma Pharmaceuticals announces $80M private placement financing 03/01/21 Satsuma Pharmaceuticals plans to begin STS101 Phase 3 trial in mid-2021 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 17:52 Today Stitch Fix slips 6.3% to about $46 after CEO transition 16:18 Today Stitch Fix CEO Lake to transition to executive chairperson role 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand SEAC SeaChange $1.38 / -0.095 (-6.46%) 03/29/21 SeaChange secures multi-million-dollar contract with broadband service in U.S. 02/11/21 SeaChange appoints Matthew Stecker to board of directors 01/13/21 SeaChange appoint Robert Pons as executive chairman, initiates CEO search SAP SAP $134.51 / +2.08 (+1.57%) 16:46 Today SAP saw 'sharp acceleration' in new cloud business in Q1 04/07/21 Accenture ,SAP co-develop Intelligent Asset Management Solutions 03/11/21 Akerna to acquire Viridian Sciences in an all-stock deal 01/27/21 SAP to acquire business process intelligence company Signavio, terms undisclosed PKI PerkinElmer $135.39 / +2.695 (+2.03%) 03/29/21 PerkinElmer's Horizon Discovery announces extention of gene modulation portfolio 03/10/21 Quidel slips, drags on peers as demand for testing 'softens significantly' 03/09/21 PerkinElmer launches comprehensive solutions for detecting SARS-CoV-2 mutations 02/23/21 PerkinElmer launches point of care Covid-19 antigen test for mass screening MRNA Moderna $149.63 / +10.34 (+7.42%) 16:37 Today Moderna jumps over 2% above $153 after update on COVID-19 variant vaccine 16:33 Today New results from Moderna's COVID-19 variant-specific vaccine show titer increase 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:28 Today Moderna says available mRNA-1273 data doesn't suggest association with CVST FLXN Flexion $9.37 / +1.05 (+12.62%) 03/31/21 Flexion announces first patient treated in FX201 Phase 1b trial 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness BRKR Bruker $68.97 / +1.43 (+2.12%) 01/11/21 Seer, Bruker sign commercial agreement for unbiased, deep proteomics 01/04/21 Bruker announces FDA clearance, U.S. launch of MBT Sepsityper Kit US IVD 12/18/20 Bruker launches FluoroType SARS-CoV-2/Flu/RSV PCR panel SAP FLXN BRKR TEAM PKI MRNA SEAC SFIX STSA SAP SAP $134.51 / +2.08 (+1.57%) 04/09/21 Societe Generale SAP price target lowered to EUR 136 from EUR 138 at Societe Generale 03/25/21 Credit Suisse SAP assumed with an Outperform at Credit Suisse 03/12/21 JMP Securities Domo price target raised to $89 from $80 at JMP Securities 03/10/21 Craig-Hallum Talend go-shop 'could spark interest,' says Craig-Hallum FLXN Flexion $9.37 / +1.05 (+12.62%) 04/06/21 RBC Capital Flexion transferred with an Outperform at RBC Capital 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations BRKR Bruker $68.97 / +1.43 (+2.12%) 02/17/21 Stifel Bruker price target raised to $65 from $48 at Stifel 02/17/21 Citi Bruker price target raised to $65 from $57 at Citi 02/05/21 Wells Fargo Bruker downgraded to Equal Weight with $55 target at Wells Fargo 02/05/21 Wells Fargo Bruker downgraded to Equal Weight from Overweight at Wells Fargo TEAM Atlassian $242.24 / +11.72 (+5.08%) 03/08/21 Morgan Stanley Software industry rating raised to Attractive from In-Line at Morgan Stanley 03/03/21 Citi Atlassian assumed with a Buy at Citi 01/29/21 DA Davidson Atlassian price target raised to $275 from $235 at DA Davidson 01/29/21 BMO Capital Atlassian price target raised to $260 from $235 at BMO Capital PKI PerkinElmer $135.39 / +2.695 (+2.03%) 02/03/21 Citi PerkinElmer price target raised to $155 from $150 at Citi 01/07/21 Piper Sandler Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo MRNA Moderna $149.63 / +10.34 (+7.42%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study SEAC SeaChange $1.38 / -0.095 (-6.46%) 09/09/20 Lake Street SeaChange price target lowered to $2 from $4 at Lake Street SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc STSA Satsuma Pharmaceuticals $5.44 / +0.37 (+7.30%) 04/05/21 Mizuho Satsuma Pharmaceuticals price target raised to $7 from $3.50 at Mizuho 03/02/21 Credit Suisse Satsuma Pharmaceuticals upgraded to Neutral from Underperform at Credit Suisse 03/02/21 Credit Suisse Satsuma upgraded to Neutral from Underperform at Credit Suisse 11/11/20 Mizuho Satsuma Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho TEAM STSA SFIX SEAC SAP PKI MRNA FLXN BRKR TEAM Atlassian $242.24 / +11.72 (+5.08%) 16:11 Today Atlassian reports preliminary Q4 revenue $566M-$572M, consensus $487.49M 01/28/21 Atlassian reports Q2 EPS 37c, consensus 32c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c STSA Satsuma Pharmaceuticals $5.44 / +0.37 (+7.30%) 03/25/21 Satsuma Pharmaceuticals reports Q4 EPS (72c), consensus (53c) SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close SEAC SeaChange $1.38 / -0.095 (-6.46%) 16:08 Today SeaChange reports Q4 EPS (9c), two estimates (10c) SAP SAP $134.51 / +2.08 (+1.57%) 16:45 Today SAP reports preliminary Q1 revenue EUR 6.35B, up 2% at constant currency 16:43 Today SAP raises FY21 cloud revenue view to EUR 9.2B-9.5B from EUR 9.1B-9.5B 01/29/21 SAP reports Q4 non-IFRS EPS EUR 1.69 vs EUR 1.82 last year 01/14/21 SAP sees FY21 non-IFRS operating profit EUR6.62B, up 48% PKI PerkinElmer $135.39 / +2.695 (+2.03%) 16:16 Today PerkinElmer sees Q1 reported revenue growth 98%, consensus $1.19B 02/02/21 PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40 02/02/21 PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88 02/02/21 PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00 MRNA Moderna $149.63 / +10.34 (+7.42%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) FLXN Flexion $9.37 / +1.05 (+12.62%) 16:18 Today Flexion sees FY21 revenue $120M-$130M, consensus $137.42M 16:17 Today Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M BRKR Bruker $68.97 / +1.43 (+2.12%) 16:12 Today Bruker sees Q1 revenue $549M-$554M, consensus $506.86M 02/16/21 Bruker sees FY 21 EPS $1.72-$1.77, consensus $1.71 02/16/21 Bruker reports Q4 EPS 58c, consensus 56c 02/16/21 Bruker reports Q4 EPS 58c, consensus 56c 30 Mar 21 Oct 21 May 19 May SAP MRNA SAP SAP $134.51 / +2.08 (+1.57%) 04/11/21 Supply-chain software provider Blue Yonder weighing IPO, WSJ reports 04/05/21 Google to stop using Oracle finance software, adopt SAP instead, CNBC says 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says MRNA Moderna $149.63 / +10.34 (+7.42%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says TEAM SFIX SEAC SAP PKI MRNA BRKR TEAM Atlassian $242.24 / +11.72 (+5.08%) 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 01/28/21 Fly Intel: After-Hours Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday 10/30/20 Fly Intel: Wall Street's top stories at midday SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Tesla upgrade, Best Buy initiation among today's top calls on Wall Street 03/09/21 Fly Intel: Pre-market Movers SEAC SeaChange $1.38 / -0.095 (-6.46%) 03/30/21 Fly Intel: Pre-market Movers SAP SAP $134.51 / +2.08 (+1.57%) 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut 01/24/21 Opening Day: Mytheresa raises $407M in U.S. market debut 12/29/20 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: Wall Street's top stories for Monday PKI PerkinElmer $135.39 / +2.695 (+2.03%) 01/07/21 Fly Intel: Pre-market Movers MRNA Moderna $149.63 / +10.34 (+7.42%) 16:27 Today Fly Intel: Wall Street's top stories for Tuesday 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers BRKR Bruker $68.97 / +1.43 (+2.12%) 11/02/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 17:00 Today SeaChange - SEAC 04/22/21 SAP - SAP 04/29/21 Atlassian - TEAM 05/04/21 PerkinElmer - PKI 05/05/21 Bruker - BRKR 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/27/21 PerkinElmer, Inc. 04/28/21 Moderna, Inc. TEAM STSA SFIX SEAC SAP MRNA TEAM Atlassian $242.24 / +11.72 (+5.08%) 03/18/21 Atlassian call volume above normal and directionally bullish 02/23/21 Atlassian call volume above normal and directionally bullish 02/22/21 Atlassian March 290 calls see heavy volume as shares dip 01/28/21 Atlassian options imply 11.5% move in share price post-earnings STSA Satsuma Pharmaceuticals $5.44 / +0.37 (+7.30%) 03/31/21 new option listings and one option delisting on March 31st SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings SEAC SeaChange $1.38 / -0.095 (-6.46%) 14:49 Today SeaChange options imply 43.3% move in share price post-earnings SAP SAP $134.51 / +2.08 (+1.57%) 01/05/21 Largest borrow rate increases among liquid names MRNA Moderna $149.63 / +10.34 (+7.42%) 10:25 Today Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish
Upgrade	South32 upgraded to Conviction Buy from Buy at Goldman Sachs » 17:57 04/13/21 04/13 17:57 04/13/21 17:57 SOUHY South32 $10.96 / -0.07 (-0.63%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SOUHY South32 $10.96 / -0.07 (-0.63%) 11/19/20 Trilogy Metals, South32 announce 2021 Upper Kobuk program and budget SOUHY South32 $10.96 / -0.07 (-0.63%) 04/07/21 Barclays South32 price target raised to 145 GBp from 130 GBp at Barclays 03/10/21 Deutsche Bank South32 price target lowered to 190 GBp from 200 GBp at Deutsche Bank 02/08/21 Barclays South32 price target raised to 130 GBp from 125 GBp at Barclays 11/24/20 Barclays South32 downgraded to Underweight from Overweight at Barclays
Upgrade	Sandfire Resources upgraded to Buy from Neutral at Goldman Sachs » 17:54 04/13/21 04/13 17:54 04/13/21 17:54 SFRRF Sandfire Resources $4.14 / -0.35 (-7.80%) Goldman Sachs analyst… Goldman Sachs analyst Paul Young upgraded Sandfire Resources to Buy from Neutral with a price target of A$7.6, up from A$5.8. The analyst is citing his higher copper price forecasts along with the company's "compelling valuation" at 0.72-times net asset value and 1.2-times expected EBITDA on next-12-month basis.
Hot Stocks	Stitch Fix slips 6.3% to about $46 after CEO transition » 17:52 04/13/21 04/13 17:52 04/13/21 17:52 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) Shares of Stitch Fix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 16:18 Today Stitch Fix CEO Lake to transition to executive chairperson role 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand 03/08/21 Stitch Fix drops 23% to $52.30 after reporting mixed Q2 results SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Tesla upgrade, Best Buy initiation among today's top calls on Wall Street 03/09/21 Fly Intel: Pre-market Movers SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
BOXL
Tomorrow at 00:00

Boxlight - BOXL Conference Calls
SLS
Tomorrow at 00:00

Sellas Life Sciences - SLS Conference Calls
Tomorrow at 00:00

Spring 2021 Transmission, Distribution, Meeting & Mutual Assistance Virtual Conference Conferences

Virtual Conference
M ...
Tomorrow at 00:00

7th Annual Virtual Retail Round-Up Conferences

Virtual Event
Tomorrow at 00:00

AACR Virtual Annual Meeting 2021 Conferences

Virtual Meeting
TCRR ...
Tomorrow at 00:00

20th Annual Virtual Healthcare Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Nvidia GTC-21 Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Private Health Virtual Forum Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse $38.40-39.60 19M Shares DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse $32.35-33.75 22M Shares IQ X IQ iQIYI Block Trade Managers: Credit Suisse $15.85-16.35 35M Shares ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Oxford halts dosing in AstraZeneca vaccine trial in children, teens, WSJ says

TODAY'S FREE FLY STORIES

Get Full Fly Access